Boehringer taps NiceLabel to launch global standardized label process

Drugs prescription pad
NiceLabel’s tools include a built-in document management system that will let Boehringer replace its manual quality control procedures with a digitized quality assurance process. (Getty/Ligorko)

Pharma manufacturer Boehringer Ingelheim has recruited label design and management systems specialist NiceLabel to develop a global standardized labeling process.

The German pharma had previously announced it would adopt a global SAP system in an effort to streamline its global operations. As part of that effort, it brought NiceLabel on board for its label management system.

RELATED: Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

NiceLabel’s tools include a built-in document management system that will let Boehringer replace its manual quality control procedures with a digitized quality assurance process. It will be integrated with Boehringer’s ERP systems, SAP ECC, which will provide a centralized way of updating label information and allow for much faster label change requests.

“It’s great to see how Boehringer Ingelheim is really using the full spectrum of our label management system,” Ken Moir, NiceLabel’s vice president of marketing, said in a statement.

RELATED: Boehringer Ingelheim opens inhaler plant with 200 jobs

Boehringer first introduced the system at its manufacturing sites in Ingelheim, Germany, and Sant Cugat, Spain. The company plans to launch the system at plants in Dortmund, Germany, and Koropi, Greece. Additionally, the system is expected to be used for non-production purposes such as warehouse and quality management.

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

CDMO Sterling Pharma Solutions is plotting a buyout of a U.K.-based antibody-drug conjugate specialist in a new bid at the next-gen cancer fighters.

Lonza will build two new manufacturing suites at its Visp, Switzerland site to handle antibody-drug conjugates for an unnamed customer.